000127425 001__ 127425
000127425 005__ 20240228140926.0
000127425 0247_ $$2doi$$a10.1186/s12943-015-0302-8
000127425 0247_ $$2pmid$$apmid:25743773
000127425 0247_ $$2pmc$$apmc:PMC4333888
000127425 0247_ $$2altmetric$$aaltmetric:3426636
000127425 037__ $$aDKFZ-2017-03448
000127425 041__ $$aeng
000127425 082__ $$a610
000127425 1001_ $$0P:(DE-HGF)0$$aRusek, Anna Maria$$b0$$eFirst author
000127425 245__ $$aMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer.319h
000127425 260__ $$aLondon$$bBiomed Central$$c2015
000127425 3367_ $$2DRIVER$$aarticle
000127425 3367_ $$2DataCite$$aOutput Types/Journal article
000127425 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524135036_24105
000127425 3367_ $$2BibTeX$$aARTICLE
000127425 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000127425 3367_ $$00$$2EndNote$$aJournal Article
000127425 520__ $$aCancer is an exceedingly complex disease that is orchestrated and driven by a combination of multiple aberrantly regulated processes. The nature and depth of involvement of individual events vary between cancer types, and in lung cancer, the deregulation of the epigenetic machinery, the tumor microenvironment and the immune system appear to be especially relevant. The contribution of microRNAs to carcinogenesis and cancer progression is well established with many reports and investigations describing the involvement of microRNAs in lung cancer, however most of these studies have concentrated on single microRNA-target relations and have not adequately addressed the complexity of their interactions. In this review, we focus, in part, on the role of microRNAs in the epigenetic regulation of lung cancer where they act as active molecules modulating enzymes that take part in methylation-mediated silencing and chromatin remodeling. Additionally, we highlight their contribution in controlling and modulating the tumor microenvironment and finally, we describe their role in the critical alteration of essential molecules that influence the immune system in lung cancer development and progression.
000127425 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000127425 588__ $$aDataset connected to CrossRef, PubMed,
000127425 650_7 $$2NLM Chemicals$$aMicroRNAs
000127425 7001_ $$0P:(DE-He78)54a8723466e5d487247f3d93d51c66bc$$aAbba, Mohammed Lawan$$b1$$udkfz
000127425 7001_ $$aEljaszewicz, Andrzej$$b2
000127425 7001_ $$aMoniuszko, Marcin$$b3
000127425 7001_ $$aNiklinski, Jacek$$b4
000127425 7001_ $$0P:(DE-He78)69067807288b48415ceb4abc43b9ad54$$aAllgayer, Heike$$b5$$eLast author$$udkfz
000127425 773__ $$0PERI:(DE-600)2091373-4$$a10.1186/s12943-015-0302-8$$gVol. 14, no. 1, p. 34 -$$n1$$p34 -$$tMolecular cancer$$v14$$x1476-4598$$y2015
000127425 909CO $$ooai:inrepo02.dkfz.de:127425$$pVDB
000127425 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000127425 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)54a8723466e5d487247f3d93d51c66bc$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000127425 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)69067807288b48415ceb4abc43b9ad54$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000127425 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000127425 9141_ $$y2015
000127425 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL CANCER : 2015
000127425 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000127425 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000127425 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000127425 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000127425 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000127425 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000127425 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000127425 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000127425 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000127425 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000127425 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000127425 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000127425 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000127425 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bMOL CANCER : 2015
000127425 9201_ $$0I:(DE-He78)G360-20160331$$kG360$$lKKE Molekulare Onkologie solider Tumoren$$x0
000127425 980__ $$ajournal
000127425 980__ $$aVDB
000127425 980__ $$aI:(DE-He78)G360-20160331
000127425 980__ $$aUNRESTRICTED